Literature DB >> 27833001

Mathematical model of Ebola transmission dynamics with relapse and reinfection.

F B Agusto1.   

Abstract

The Ebola virus disease is caused by the Ebola virus which belongs to the filoviridae virus family. The 2014 outbreaks were estimated to have caused over 11,000 fatalities. In this paper, we formulate and analyze a system of ordinary differential equations which incorporates disease relapse and reinfection. The Ebola model with disease relapse and reinfection is locally-asymptotically stable when the basic reproduction number is less than unity. The model exhibits in the presence of disease reinfection, the phenomenon of backward bifurcation, where the stable disease-free equilibrium co-exists with a stable endemic equilibrium when the associated reproduction number is less than unity. The feasibility of backward bifurcation occurring increases with increasing values of both relapse and reinfection. The total number of new cases of Ebola-infected individuals increases with increasing values of the relapse and reinfection parameters. Further simulations show that Ebola transmission models that do not incorporate relapse and reinfection may under-estimate disease burden in the community. Similar under-estimation is observed in models that include only one infected and recovered classes. Using results obtained from sensitivity analysis indicates that Ebola (given disease relapse and reinfection) can be effectively curtailed in the community by using control measures with a high-effectiveness level. This strategy is more effective than either the moderate- or low-effectiveness levels.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Backward bifurcation; Control intervention; Ebola; Reinfection; Relapse; Sensitivity analysis

Mesh:

Year:  2016        PMID: 27833001     DOI: 10.1016/j.mbs.2016.11.002

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  8 in total

1.  A drug-disease model for predicting survival in an Ebola outbreak.

Authors:  Masood Khaksar Toroghi; Nidal Al-Huniti; John D Davis; A Thomas DiCioccio; Ronda Rippley; Alina Baum; Christos A Kyratsous; Sumathi Sivapalasingam; Joel Kantrowitz; Mohamed A Kamal
Journal:  Clin Transl Sci       Date:  2022-08-17       Impact factor: 4.438

2.  Transmission dynamics of SARS-CoV-2: A modeling analysis with high-and-moderate risk populations.

Authors:  Salihu S Musa; Isa A Baba; Abdullahi Yusuf; Tukur A Sulaiman; Aliyu I Aliyu; Shi Zhao; Daihai He
Journal:  Results Phys       Date:  2021-05-19       Impact factor: 4.476

3.  Cooperative system analysis of the Ebola virus epidemic model.

Authors:  Karima Kabli; Soumia El Moujaddid; Khadija Niri; Abdessamad Tridane
Journal:  Infect Dis Model       Date:  2018-09-22

4.  Effect of sexual transmission on the West Africa Ebola outbreak in 2014: a mathematical modelling study.

Authors:  Dongmei Luo; Rongjiong Zheng; Duolao Wang; Xueliang Zhang; Yi Yin; Kai Wang; Weiming Wang
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

5.  Effects of environmental variability on superspreading transmission events in stochastic epidemic models.

Authors:  Nika Shakiba; Christina J Edholm; Blessing O Emerenini; Anarina L Murillo; Angela Peace; Omar Saucedo; Xueying Wang; Linda J S Allen
Journal:  Infect Dis Model       Date:  2021-03-18

Review 6.  Statistical Modeling for the Prediction of Infectious Disease Dissemination With Special Reference to COVID-19 Spread.

Authors:  Subhash Kumar Yadav; Yusuf Akhter
Journal:  Front Public Health       Date:  2021-06-16

7.  Ebola could be eradicated through voluntary vaccination.

Authors:  Andrew Brettin; Rosa Rossi-Goldthorpe; Kyle Weishaar; Igor V Erovenko
Journal:  R Soc Open Sci       Date:  2018-01-24       Impact factor: 2.963

8.  To isolate or not to isolate: the impact of changing behavior on COVID-19 transmission.

Authors:  Folashade B Agusto; Igor V Erovenko; Alexander Fulk; Qays Abu-Saymeh; Daniel Romero-Alvarez; Joan Ponce; Suzanne Sindi; Omayra Ortega; Jarron M Saint Onge; A Townsend Peterson
Journal:  BMC Public Health       Date:  2022-01-20       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.